Replies to post #200997 on Biotech Values

[caravon]

I get an impression that ABBV's CEO makes up numbers as he goes.

[vinmantoo]

ABBV’s 2016 V-Pak guidance of $2B should be doable with ramping sales in Japan, but it’s apparently not a lowball figure as I had presumed.

Yes, but it is well down from the $3 billion run rate ABBV was predicting early on for V-Pak to reach by the end of 2015. It is very disappointing to me.